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apoptosis. Loss-of-function mutations in IKBKG, as occurs in IP, leave mutant cells vulnerable to apoptosis when exposed to tumour necrosis factor alpha. 1 Females with IP who inherit germline mutations in IKBKG usually survive because of skewed X-inactivation favouring expression of the wild-type allele, whereas most males with IP die in utero. However, possible explanations for rare examples of male IP survival include: Klinefelter syndrome (47XXY), hypomorphic IKBKG mutations, and post-zygotic mutations in IKBKG leading to somatic mosaicism. 2 Here, we describe an adult male with IP, with survival being attributed to tissue mosaicism, who then fathered a female child with IP affecting her germline. Following informed consent, a three-primer PCR protocol was used to screen for the most common recurrent pathogenic mutation in IKBKG that underlies ~80% of IP cases worldwide, an intragenic deletion from within intron 3 to within intron 10 that removes all of exons 4-10. 1 Such a PCR protocol is necessary because of a non-functional copy of IKBKG running in the opposite
direction. We used a recently reported method, 3 that represents an improvement over other protocols because of its capacity to non-preferentially amplify both wild-type and deletion mutant IKBKG alleles (c.f. some other protocols that favour amplification of the wild-type allele because of GC nucleotide mismatch).
This PCR protocol ( Figure 2 ) failed to demonstrate presence of the common deletion in IKBKG in the father's genomic DNA extracted from his peripheral blood. However, the deletion was clearly identified in his lesional skin DNA and, to a much lesser extent, in his non-lesional skin DNA.
In contrast to the father, the deletion was present in peripheral blood genomic DNA from his daughter. Presence of all deletions was confirmed by Sanger sequencing (data not shown). The clinical phenotype in this family infers that the father must be a tissue mosaic for the IP deletion mutation that has unexpectedly also affected the gonads and hence been transmitted to his daughter as a germline abnormality. Her clinical signs reflect skewed X-inactivation, resulting in survival, as is the case for most affected females.
To our knowledge, there are only three previous reports of father-to-daughter transmission of IP. Two cases were similar to ours, with a history of probable tissue mosaicism in the fathers, 4, 5 although the clinical descriptions predated the discovery of IKBKG mutations in IP and thus neither of these cases had supportive molecular pathology. One other report described a clinically unaffected father having two daughters with IP (born to different mothers). 6 The lack of clinical abnormalities in the father in that case is consistent with gonadal mosaicism, although again the report was published before the discovery of IKBKG as the IP gene. Thus our fourth case represents the first example of father to daughter transmission of IP in which a pathogenic mutation in IKBKG has been demonstrated.
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